Polaryx Therapeutics PLYX
NASDAQ PLYX
$1.94 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Polaryx Therapeutics (PLYX) Net Cash Flow (2025 - 2026)

Updated

Polaryx Therapeutics (PLYX) reported Net Cash Flow of -$1.33 million for Q2 2026, compared with -$891,000 a year earlier.

Analysis

Polaryx Therapeutics (PLYX) Net Cash Flow (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Polaryx Therapeutics' Net Cash Flow came in at -$4.78 million; for FY2025, it was $522,000, down 88.6% from FY2024.

  • By year, Net Cash Flow came in at $4.59 million in FY2024.
  • Five-year quarterly Net Cash Flow spans a low of -$2.1 million in Q1 2026 and a high of -$459,000 in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 3.72 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -3.52 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -2.82 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 1.53 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 757.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -3.94 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 1.95 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -4.43 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -722.00 Mn
10 Polaryx Therapeutics 93.18 Mn 68.79 Mn - -1.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.33 Mn
Mar 31, 2026 -2.10 Mn
Jun 30, 2025 -891,000.00
Mar 31, 2025 -459,000.00
API Access

Polaryx Therapeutics Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=PLYX&period=max&api_key=YOUR_API_KEY